Celsius Holdings (CELH) Gets a Buy from Roth MKM
Roth MKM analyst Sean McGowan maintained a Buy rating on Celsius Holdings (CELH – Research Report) today and set a price target of $52.00. The company's shares closed yesterday at $45.47.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, McGowan is ranked #821 out of 9622 analysts.
Currently, the analyst consensus on Celsius Holdings is a Moderate Buy with an average price target of $45.86, representing a 0.86% upside. In a report released on June 18, TD Cowen also upgraded the stock to a Buy with a $55.00 price target.
The company has a one-year high of $61.25 and a one-year low of $21.10. Currently, Celsius Holdings has an average volume of 7.62M.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Kymera weakness a buying opportunity, says Stifel
Stifel analyst Alex Thompson is reiterating a Buy rating on Kymera Therapeutics (KYMR) following 'a slate of updates,' including the decision by partner Sanofi (SNY) to discontinue development of lead IRAK4 degrader KT-474 in favor of next-gen KT-485 and a new partnership deal with Gilead (GILD) for a CDK2 molecular glue degrader. While the update related to IRAK4 is 'disappointing and removes potential catalysts' next year, Sanofi expects to move KT-485 into Phase 1 next year and the broader partnership remains in place, notes the analyst. On the Gilead deal, Kymera will receive up to $85M in upfront and options, adds the analyst, who would view any weakness from today's news as a buying opportunity as the firm contends there remains limited credit in the stock for the broader pipeline and additional milestone payments. Stifel has a Buy rating on Kymera shares, which are down $1.18, or 2.5%, to $45.96 in morning trading. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on KYMR: Disclaimer & DisclosureReport an Issue Morning Movers: General Mills dips following fourth quarter report Kymera Therapeutics Partners with Gilead for Oncology Treatment Kymera Therapeutics Advances KT-485 in Sanofi Collaboration Gilead sees Kymera deal lowering 2025 EPS by 2c-3c Gilead, Kymera enter license agreement for molecular glue degrader program
Yahoo
26 minutes ago
- Yahoo
Conagra to complete removal of FD&C colors from frozen portfolio by year-end
Conagra Brands (CAG) will reach an important milestone in the company's long-standing portfolio modernization strategy by completing the removal of certified Food, Drug & Cosmetic colors from its U.S. frozen product portfolio by the end of 2025. Additionally, Conagra will continue its portfolio modernization efforts across its full U.S. retail portfolio and will not offer products with FD&C colors sold to K-12 schools by the beginning of the 2026-2027 school year. The company is also working to discontinue the use of FD&C colors in the manufacturing of products across its U.S. retail portfolio by the end of 2027. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on CAG: Disclaimer & DisclosureReport an Issue Conagra Brands price target lowered to $20.50 from $22 at TD Cowen Food, agriculture leaders warn of MAHA's overreach, WSJ reports Conagra Brands Director Fran Horowitz to Step Down UBS Maintains Hold Rating on Conagra Brands Amidst Growth Challenges and Valuation Concerns Conagra Brands initiated with a Neutral at UBS
Yahoo
27 minutes ago
- Yahoo
Option traders moderately bearish in Snowflake with shares down 0.1%
Option traders moderately bearish in Snowflake (SNOW), with shares down 23c near $222.91. Options volume relatively light with 12k contracts traded and calls leading puts for a put/call ratio of 0.25, compared to a typical level near 0.52. Implied volatility (IV30) is higher by 1.9 points near 31.94,in the lowest 10% of observations over the past year, suggesting an expected daily move of $4.48. Put-call skew steepened, indicating increased demand for downside protection. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on SNOW: Disclaimer & DisclosureReport an Issue DA Davidson technology analysts hold an analyst/industry conference call Snowflake price target raised to $250 from $220 at KeyBanc Lyft upgraded, Block assumed: Wall Street's top analyst calls Snowflake assumed with an Overweight at Morgan Stanley Snowflake's Strategic Advancements and AI Focus Drive Buy Rating with 20% Growth Outlook Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
